Can Medical Treatments Cause Alzheimer’s Disease?

In the ever-evolving world of Alzheimer’s research, a groundbreaking study published just last week has thrown light on a potential third cause of Alzheimer’s disease, which might just change everything we thought we knew about this complex condition.

Is Alzheimer’s Just About Forgetting?

When most of us think about Alzheimer’s, images of forgetfulness and confusion come to mind—symptoms that are prevalent in the later stages. However, the journey of Alzheimer’s begins much earlier and far more subtly than many realize.

The Known Paths to Alzheimer’s

Alzheimer’s disease typically falls into two categories: ‘sporadic’ and ‘familial.’ Most people encounter the sporadic type, where factors like genetics, lifestyle, and the environment play a role, often emerging later in life. On the flip side, the familial form of Alzheimer’s, though much rarer, comes from specific genes making it a certainty for those affected, usually striking before the age of 65.

Iatrogenic Alzheimer’s

But here’s where the plot thickens—the study introduced us to iatrogenic Alzheimer’s disease, a term suggesting that Alzheimer’s could be acquired through medical treatments. Yes, you read that right.

Hormone Treatments Gone Wrong

Between 1959 and 1989, a treatment involving cadaveric human growth hormone was administered to children in the UK, aiming to aid conditions like failure to thrive. Unfortunately, this treatment led to the tragic death of 80 recipients due to Creutzfeldt-Jakob disease (CJD), linked to contaminated beta-amyloid, a protein found in the brains of people who have Alzheimer’s disease, that the hormone was contaminated with. Fortunately, this particular procedure isn’t done any longer.

Fast Forward: The Third Cause Emerges

The current study focused on eight individuals who underwent this treatment and survived, only to face early onset dementia years later—this has led researchers to conclude that Alzheimer’s can be triggered through medical treatments, a concept previously unimagined. Basically the contaminated beta-amyloid tissue seems to have caused Alzheimer’s in the the study participants.

What This Means for the Future

Ensuring safe procedures, clean instruments and uncontaminated tissue is essential and must be addressed. But this revelation isn’t just a cautionary tale about medical procedures; it opens new doors for Alzheimer’s research, presenting a unique angle on prevention and treatment strategies.

Is Alzheimer’s Contagious?

Does this research make you wonder if Alzheimer’s can be passed from one person to another? Don’t worry– Alzheimer’s disease cannot be caught through everyday interactions or caregiving. The study zeroes in on rare cases where Alzheimer’s arises from specific medical treatments, not from casual contact.

Join the Conversation:

This discovery opens up many questions and possibilities. What are your thoughts on this new cause of Alzheimer’s? What do you think? Surprised, intrigued, or got a question bubbling up? Drop it in the comments below. Let’s keep this conversation going.

Dive Deeper with Links and Resources

Curious to explore the groundbreaking medical study that inspired today’s discussion? Dive into the full study here.

And if you’re more of a visual learner, I’ve got you covered! Check out my detailed video breakdown of this topic on YouTube. Watch the video now and join the conversation in the comments!

Want to watch the in-depth video that inspired this post?

Click the video below to watch. ↓

Know someone in your family who should read this?

Email them this article
Dr. Natali Edmonds

Dr. Natali Edmonds

Dr. Natali Edmonds is a board-certified geropsychologist and the founder of Dementia Careblazers. She has spent her career working with families caring for a loved one with dementia, and publishes a new video for caregivers every week.

More articles

Two headlines about Ozempic and other GLP-1 drugs and Alzheimer's seem to contradict each other; one says semaglutide may cut risk by up to 70 percent, another says a major trial found no benefit. Dr. Natali explains why both are true, breaking down the difference between prevention and treatment research and what it means for caregivers and their loved ones.
A major research organization published a review in April 2026 saying new Alzheimer's drugs offer trivial benefit. But the scientific debate is more complicated than the headlines suggest. Dr. Natali breaks down what the Cochrane review actually found, why researchers are pushing back, and the three questions to bring to your loved one's neurologist.
A new Alzheimer’s blood test can detect changes years before symptoms appear. Learn what it means for diagnosis and caregivers.

See all articles

Get the Dementia Dose, a free email every Thursday.

One short email a week from Dr. Natali, about the parts of caregiving no one prepares you for.

    Free. Unsubscribe anytime, in one click.

    Discover more from Dementia Careblazers

    Subscribe now to keep reading and get access to the full archive.

    Continue reading

    Skip to content